152 related articles for article (PubMed ID: 19401121)
1. Association of the plasminogen activator inhibitor-1 gene 4G/5G polymorphism with ST elevation acute myocardial infarction in young patients.
Isordia-Salas I; Leaños-Miranda A; Sainz IM; Reyes-Maldonado E; Borrayo-Sánchez G
Rev Esp Cardiol; 2009 Apr; 62(4):365-72. PubMed ID: 19401121
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
Cagliyan CE; Yuregir OO; Balli M; Tekin K; Akilli RE; Bozdogan ST; Turkmen S; Deniz A; Baykan OA; Aslan H; Cayli M
Coron Artery Dis; 2013 May; 24(3):196-200. PubMed ID: 23283030
[TBL] [Abstract][Full Text] [Related]
3. PAI-1 4G/5G gene polymorphism is associated with angiographic patency in ST-elevation myocardial infarction patients treated with thrombolytic therapy.
Ozkan B; Cagliyan CE; Elbasan Z; Uysal OK; Kalkan GY; Bozkurt M; Tekin K; Bozdogan ST; Ozalp O; Duran M; Sahin DY; Cayli M
Coron Artery Dis; 2012 Sep; 23(6):400-3. PubMed ID: 22850480
[TBL] [Abstract][Full Text] [Related]
4. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
[TBL] [Abstract][Full Text] [Related]
5. The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes.
Iwai N; Shimoike H; Nakamura Y; Tamaki S; Kinoshita M
Atherosclerosis; 1998 Jan; 136(1):109-14. PubMed ID: 9544737
[TBL] [Abstract][Full Text] [Related]
6. An effect of the PAI-1 4G/5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke.
Boncoraglio GB; Bodini A; Brambilla C; Carriero MR; Ciusani E; Parati EA
Cerebrovasc Dis; 2006; 22(2-3):191-5. PubMed ID: 16735791
[TBL] [Abstract][Full Text] [Related]
7. Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction.
Rallidis LS; Gialeraki A; Merkouri E; Liakos G; Dagres N; Sionis D; Travlou A; Lekakis J; Kremastinos DT
J Thromb Thrombolysis; 2010 May; 29(4):497-502. PubMed ID: 19844663
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 4G/5G gene polymorphism in patients with myocardial or cerebrovascular infarction in Tianjin, China.
Zhan M; Zhou Y; Han Z
Chin Med J (Engl); 2003 Nov; 116(11):1707-10. PubMed ID: 14642142
[TBL] [Abstract][Full Text] [Related]
9. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction.
Doggen CJ; Bertina RM; Cats VM; Reitsma PH; Rosendaal FR
Thromb Haemost; 1999 Jul; 82(1):115-20. PubMed ID: 10456464
[TBL] [Abstract][Full Text] [Related]
10. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
Fu L; Jin H; Song K; Zhang C; Shen J; Huang Y
Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
[TBL] [Abstract][Full Text] [Related]
11. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
[TBL] [Abstract][Full Text] [Related]
12. Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction.
Anderson JL; Muhlestein JB; Habashi J; Carlquist JF; Bair TL; Elmer SP; Davis BP
J Am Coll Cardiol; 1999 Nov; 34(6):1778-83. PubMed ID: 10577569
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 4G/5G-polymorphism and factor V Q506 mutation are not associated with myocardial infarction in young men.
Junker R; Heinrich J; Schulte H; Tataru M; Köhler E; Schönfeld R; Nowak-Göttl U; Assmann G
Blood Coagul Fibrinolysis; 1998 Oct; 9(7):597-602. PubMed ID: 9863707
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
Guan LX; Du XY; Wang JX; Wang RL; Wu ZL; Jiang H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):173-5. PubMed ID: 15079805
[TBL] [Abstract][Full Text] [Related]
15. The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women.
Hindorff LA; Schwartz SM; Siscovick DS; Psaty BM; Longstreth WT; Reiner AP
J Cardiovasc Risk; 2002 Apr; 9(2):131-7. PubMed ID: 12006921
[TBL] [Abstract][Full Text] [Related]
16. [The study of PAI-1 promotor region gene polymorphism in cerebrovascular disease].
Zhang C; Li J; Li L; Luo B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):383-7. PubMed ID: 11592048
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 promoter 4G/5G genotype is not a risk factor for myocardial infarction in a Japanese population.
Sugano T; Tsuji H; Masuda H; Nakagawa K; Nishimura H; Kasahara T; Yoshizumi M; Nakahara Y; Kitamura H; Yamada K; Yoneda M; Maki K; Tatsumi T; Azuma A; Nakagawa M
Blood Coagul Fibrinolysis; 1998 Mar; 9(2):201-4. PubMed ID: 9622220
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography.
Ossei-Gerning N; Mansfield MW; Stickland MH; Wilson IJ; Grant PJ
Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):33-7. PubMed ID: 9012634
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children.
Berberoğlu M; Evliyaoğlu O; Adiyaman P; Ocal G; Ulukol B; Simşek F; Siklar Z; Törel A; Ozel D; Akar N
J Pediatr Endocrinol Metab; 2006 May; 19(5):741-8. PubMed ID: 16789641
[TBL] [Abstract][Full Text] [Related]
20. The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study.
Juhan-Vague I; Morange PE; Frere C; Aillaud MF; Alessi MC; Hawe E; Boquist S; Tornvall P; Yudkin JS; Tremoli E; Margaglione M; Di Minno G; Hamsten A; Humphries SE;
J Thromb Haemost; 2003 Nov; 1(11):2322-9. PubMed ID: 14629464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
